Immunogenicity & Safety Study of GSK's MenABCWY Vaccine in Healthy

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04689191` - A Phase III Clinical Trial of the Group A and C Meningococcal Polysaccharide Vaccine	Phase 3
Recruiting	`NCT04689165` - A Phase III Clinical Trial of the Group A Meningococcal Polysaccharide Vaccine	Phase 3
Completed	`NCT00780806` - Safety And Blood Collection Study Of Meningococcal B Rlp2086 Vaccine In Adults	Phase 1/Phase 2
Completed	`NCT03378258` - Petechiae In Children (PIC) Study: Defining A Clinical Decision Rule for The Management Of Fever and Non-Blanching Rashes In Children Including The Role Of Point Of Care Testing For Procalcitonin & Neisseria Meningitidis DNA.
Completed	`NCT03205371` - Immunogenicity and Safety of a Meningococcal Conjugate Vaccine Given Concomitantly With Other Vaccines in Toddlers	Phase 3
Completed	`NCT01352793` - A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years	Phase 3
Not yet recruiting	`NCT06113198` - A Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Healthy Infants From 2 Months of Age	Phase 4
Completed	`NCT03295318` - Clinical Study of Meningococcal ACYWX Conjugate Vaccine, in 12-16 Month Olds	Phase 2
Completed	`NCT03493919` - A Sourcing Study to Collect Human Blood Samples From Healthy Adults	Phase 4
Completed	`NCT00474526` - A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants	Phase 3
Completed	`NCT00297687` - Study Evaluating the Safety, Immunogenicity and Tolerability of Meningococcal Group B Vaccine in Healthy Adults	Phase 1
Recruiting	`NCT04665791` - A Human Controlled Infection Study With Neisseria Lactamica in Malian Adults	N/A
Withdrawn	`NCT03431675` - Ciprofloxacin for the Prevention of Meningococcal Meningitis 2018	Phase 4
Recruiting	`NCT02878291` - Safety Study of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Healthy Volunteers Aged Above 3 Months	Phase 1
Completed	`NCT00314041` - Study Evaluating the Tolerance of Conjugate Meningococcal C Vaccine in Infants	Phase 2
Recruiting	`NCT04685850` - Long-term Sequelae of Childhood Meningitis and Meningococcal Purpura Fulminans
Completed	`NCT03587207` - Study to Assess Potential Immune Interference When GlaxoSmithKline (GSK) Biologicals' MenABCWY Vaccine is Administered to Healthy Subjects Aged 10-25 Years	Phase 2
Completed	`NCT03824093` - High and Low Resource Interventions to Promote HPV Vaccines	N/A
Terminated	`NCT00798304` - Study Evaluating Safety, Tolerability, and Immunogenicity of Meningococcal B Vaccine in Healthy Infants	Phase 2
Recruiting	`NCT03682939` - Evaluation of Safety and Immunogenicity of Meningococcal B and Meningococcal ACWY Vaccine in at Risk Population	Phase 4

NCT number	NCT04707391
Study type	Interventional
Source	GlaxoSmithKline
Contact
Status	Completed
Phase	Phase 3
Start date	January 25, 2021
Completion date	September 29, 2023

Immunogenicity and Safety Study of GSK's MenABCWY Vaccine in Healthy Adolescents and Adults Previously Primed With MenACWY Vaccine

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms